Hamilton Medical AG
Hamilton Medical AG, headquartered in Switzerland (CH), is a leading innovator in the medical technology industry, specialising in advanced ventilation solutions. Founded in 1983, the company has established a strong presence in Europe, North America, and Asia, focusing on critical care and anaesthesia. Hamilton Medical is renowned for its cutting-edge ventilators and intelligent ventilation software, which enhance patient outcomes through precision and adaptability. Their flagship products, such as the HAMILTON-G5 and HAMILTON-C6, are distinguished by their unique features, including adaptive support modes and user-friendly interfaces. With a commitment to research and development, Hamilton Medical AG has achieved significant milestones, positioning itself as a trusted partner in hospitals worldwide. The company’s dedication to innovation and quality has earned it a prominent market position, making it a preferred choice among healthcare professionals in critical care settings.
DitchCarbon Score
How does Hamilton Medical AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hamilton Medical AG's score of 34 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hamilton Medical AG's reported carbon emissions
In 2020, Hamilton Medical AG reported total carbon emissions of approximately 101,064,200 kg CO2e. This figure includes Scope 1 emissions of about 1,337,000 kg CO2e, primarily from mobile and stationary combustion, and Scope 2 emissions of approximately 296,500 kg CO2e, mainly from purchased electricity and heat. The majority of their emissions, around 100,634,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions from the supply chain, including capital goods and the use of sold products. Looking ahead, Hamilton Medical AG has set ambitious climate commitments in line with the Science Based Targets initiative (SBTi). They aim to reduce their absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the baseline year. Additionally, they plan to cut Scope 3 emissions by 52% per CHF value added within the same timeframe. These targets reflect a strong commitment to sustainability and align with global efforts to limit warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | |
|---|---|
| Scope 1 | 133,700 |
| Scope 2 | 296,500 |
| Scope 3 | 100,634,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hamilton Medical AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
